ESC Premium Access

About the speaker

Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
9 presentations
1 follower

3 more presentations in this session

When should I use reversal agents for NOACs?

Speaker: Professor G. Lip (Liverpool, GB)


Reversal of FXa inhibitors.

Speaker: Associate Professor S. Wassmann (Munich, DE)


Will the availability of specific reversal agents change the use of NOACs?

Speaker: Professor F. Verheugt (Amsterdam, NL)


Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Professor A. Niessner, Professor G. Lip, Associate Professor S. Wassmann, Professor F. Verheugt

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb